{
    "SPADE_N_14543": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14543",
            "Peptide Name": "LM6 (Lactomodulin fragment, Synthetic AMPs, XXA, UCLL1c)",
            "Source": "sequence truncation, bacteria-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "LSKISGGIGPLVIPV",
            "Sequence Length": 15,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1449.78,
            "PI": 8.75,
            "Hydrophobicity": 1.31,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Mousa WK, Shaikh AY, Ghemrawi R, Aldulaimi M, Al Ali A, Sammani N, Khair M, Helal MI, Al-Marzooq F, Oueis E. 2024",
                    "Reference": "RSC Med Chem. 2024 Oct 28. doi: 10.1039/d4md00383g.PubMed",
                    "Title": "Human microbiome derived synthetic antimicrobial peptides with activity against Gram-negative, Gram-positive, and antibiotic resistant bacteria."
                }
            ],
            "Frequent Amino Acids": "GIL",
            "Absent Amino Acids": "ACDEFHMNOQRTUWY",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 5,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "Net Charge": 1,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (66.67%) toLM2I=G: 20%.Activity: active against S. aureus ATCC 25923 or MRSA BAA 2313 (MIC 0.9-1.7 uM),  C. difficile ATCC 43602 (MIC 0.9 uM), L. monocytogenes ATCC 15313 (MIC 2.3 uM), E. faecium anti-VRE BAA 2317 (MIC 1.3 uM), E. coli ATCC 33694 (MIC 9.2 uM), P. aeruginosa BAA 1744 (MIC 9.3 uM), and S.enterica ATCC 13314 (NA). NA: not observed.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05168",
                    "Similarity": 1.0,
                    "Sequence": "LPETHRQTSSGALIFKPTIAEQEHKNAMESIKQERTELEKELANVKAIKDELSKELADIKQLKDELSK"
                },
                {
                    "SPADE_ID": "SPADE_N_06285",
                    "Similarity": 1.0,
                    "Sequence": "ALSKALSKALSKALSKALSKALSK"
                },
                {
                    "SPADE_ID": "SPADE_N_11760",
                    "Similarity": 1.0,
                    "Sequence": "ALKSLLKTLSKAKAAKLKTLLKALSK"
                }
            ]
        }
    }
}